NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has received notification that CE Mark approval has been granted for LuViva ® Advanced ...

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that its ...

Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new ...

SAN FRANCISCO--(BUSINESS WIRE)-- Millions of women around the world who do not have access to Pap test screening for cervical cancer could benefit from a non-invasive test that scans the cervix with ...

ST. LOUIS - A machine invented at Washington University to reveal the inner workings of brains and hearts is emerging as a premier tool for tracking cervical cancer. The device, called a positron ...

NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCBB: GTHP) announced that it filed its completed premarket approval application (PMA) for the LightTouch™ Cervical Scanner with the U.S.

NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced that the company plans to seek an independent panel review of its Pre-market Approval (PMA) application ...

Those yellow and blue spots on the cervix indicate diseased, possibly cancerous tissue made visible by the experimental LUMA Cervical Imaging System. The spots might have been missed by a standard ...